Xueying Wu
-
- Cancer Immunotherapy and Biomarkers 8
- Pancreatic and Hepatic Oncology Research 2
-
- Immunotherapy and Immune Responses 3
-
- MicroRNA in disease regulation 3
- Cancer Genomics and Diagnostics 3
-
- Ferroptosis and cancer prognosis 3
-
- Parathyroid Disorders and Treatments 2
-
- Pancreatitis Pathology and Treatment 2
- Co-authors
- Henghui ZhangYing HuBeibei MaoHuan ChenYue FanLijia WuYing YangJunyan Han
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Xueying Wu
31 papers receiving 199 citations
Peers
Comparison fields: 5 of 63
- Oncology 77
- Immunology 53
- Cancer Research 29
- Pathology and Forensic Medicine 26
- Pulmonary and Respiratory Medicine 37
Countries citing papers authored by Xueying Wu
This map shows the geographic impact of Xueying Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueying Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueying Wu more than expected).
Fields of papers citing papers by Xueying Wu
This network shows the impact of papers produced by Xueying Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueying Wu. The network helps show where Xueying Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xueying Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 5 | |
| 4 | 2024 | 15 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2022 | 23 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2021 | 13 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2020 | 2 | |
| 19 | 2017 | 6 | |
| 20 | 2016 | 25 |
About Xueying Wu
Xueying Wu is a scholar working on Oncology, Cancer Research and Immunology, having authored 35 papers that have together received 199 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), MicroRNA in disease regulation (3 papers), Ferroptosis and cancer prognosis (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Genomics and Diagnostics (3 papers), Parathyroid Disorders and Treatments (2 papers), Pancreatitis Pathology and Treatment (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Oncology (77 citations), Immunology (53 citations) and Cancer Research (29 citations). Xueying Wu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Henghui Zhang, Ying Hu, Beibei Mao, Huan Chen, Yue Fan, Lijia Wu, Ying Yang, Junyan Han, Hao Yu and Hui Zeng. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.